导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 40.23% | 101/1050 |
| 近一周 | 2.94% | 97/1104 |
| 近一月 | -8.13% | 819/1103 |
| 近一季 | -22.91% | 989/1094 |
| 近半年 | 39.58% | 67/1074 |
| 近一年 | 42.34% | 105/1020 |
| 近两年 | 149.82% | 108/926 |
| 近三年 | 104.87% | 92/834 |
| 成立以来 | 104.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.59% 601/1070 |
98.02% 50/1101 |
- - |
- - |
| 2025 | 47.76% 218/1065 |
3.94% 483/1014 |
2.48% 470/1038 |
37.30% 241/1050 |
1.04% 394/1065 |
| 2024 | 2.81% 507/1011 |
-1.09% 373/960 |
-2.76% 490/983 |
8.27% 763/991 |
-1.27% 400/1011 |
| 2023 | -22.01% 721/952 |
-1.22% 677/880 |
-1.05% 242/895 |
-17.29% 823/915 |
-3.53% 376/952 |
| 2022 | -32.94% 677/867 |
-22.71% 661/773 |
5.96% 459/806 |
-7.91% 136/845 |
-11.08% 807/867 |
| 2021 | 11.20% 227/740 |
-9.34% 475/580 |
14.30% 250/659 |
11.94% 47/704 |
-4.14% 574/740 |
| 2020 | 99.82% 32/554 |
16.03% 18/419 |
23.58% 219/466 |
11.12% 224/517 |
25.41% 63/554 |
| 2019 | 46.61% 176/410 |
29.22% 417/1149 |
-6.78% 835/1231 |
11.14% 96/390 |
9.52% 173/410 |
| 2018 | - - |
- - |
- - |
- - |
-11.72% 517/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 招商中国机遇股票 VS. 东吴新产业精选股票A(580008) |